Mayanja-Kizza H - Search Results

1

A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups. Zak DE, et al. Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24. Lancet. 2016. PMID: 27017310 Free PMC article.

2

A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.

Wallis RS, Kyambadde P, Johnson JL, Horter L, Kittle R, Pohle M, Ducar C, Millard M, Mayanja-Kizza H, Whalen C, Okwera A. Wallis RS, et al. AIDS. 2004 Jan 23;18(2):257-64. doi: 10.1097/00002030-200401230-00015. AIDS. 2004. PMID: 15075543 Clinical Trial.

3

Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.

Srikantiah P, Walusimbi MN, Kayanja HK, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois ED, Boom WH, Whalen CC, Havlir DV. Srikantiah P, et al. AIDS. 2007 Sep 12;21(14):1972-4. doi: 10.1097/QAD.0b013e32823ecf6e. AIDS. 2007. PMID: 17721107 Free PMC article.

4

Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda.

Lewinsohn DA, Zalwango S, Stein CM, Mayanja-Kizza H, Okwera A, Boom WH, Mugerwa RD, Whalen CC. Lewinsohn DA, et al. PLoS One. 2008;3(10):e3407. doi: 10.1371/journal.pone.0003407. Epub 2008 Oct 15. PLoS One. 2008. PMID: 18923705 Free PMC article.

5

Genome scan of M. tuberculosis infection and disease in Ugandans.

Stein CM, Zalwango S, Malone LL, Won S, Mayanja-Kizza H, Mugerwa RD, Leontiev DV, Thompson CL, Cartier KC, Elston RC, Iyengar SK, Boom WH, Whalen CC. Stein CM, et al. PLoS One. 2008;3(12):e4094. doi: 10.1371/journal.pone.0004094. Epub 2008 Dec 31. PLoS One. 2008. PMID: 19116662 Free PMC article.

6

Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.

Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, Chervenak KA, Mugerwa RD, Havlir DV, Mayanja-Kizza H, Whalen CC, Boom WH; Uganda-Case Western Research Collaboration. Mahan CS, et al. PLoS One. 2010 Feb 22;5(2):e9138. doi: 10.1371/journal.pone.0009138. PLoS One. 2010. PMID: 20179751 Free PMC article. Clinical Trial.

7

Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation.

Toossi Z, Hirsch CS, Wu M, Mayanja-Kizza H, Baseke J, Thiel B. Toossi Z, et al. Clin Exp Immunol. 2011 Mar;163(3):333-8. doi: 10.1111/j.1365-2249.2010.04269.x. Clin Exp Immunol. 2011. PMID: 21303360 Free PMC article.

8

Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study.

Baker AR, Zalwango S, Malone LL, Igo RP Jr, Qiu F, Nsereko M, Adams MD, Supelak P, Mayanja-Kizza H, Boom WH, Stein CM. Baker AR, et al. Hum Immunol. 2011 May;72(5):426-30. doi: 10.1016/j.humimm.2011.02.016. Epub 2011 Feb 25. Hum Immunol. 2011. PMID: 21354459 Free PMC article.

9

Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.

Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, Nalukwago S, Charlebois E, Havlir D, Mayanja-Kizza H, Whalen CC, Boom WH. Lancioni CL, et al. J Infect Dis. 2011 Apr 1;203(7):992-1001. doi: 10.1093/infdis/jiq141. J Infect Dis. 2011. PMID: 21402550 Free PMC article. Clinical Trial.

10

A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.

Nanteza MW, Mayanja-Kizza H, Charlebois E, Srikantiah P, Lin R, Mupere E, Mugyenyi P, Boom WH, Mugerwa RD, Havlir DV, Whalen CC. Nanteza MW, et al. J Infect Dis. 2011 Sep 15;204(6):884-92. doi: 10.1093/infdis/jir503. J Infect Dis. 2011. PMID: 21849285 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page